Literature DB >> 5134998

Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.

L Nathanson, J Wolter, J Horton, J Colsky, B I Shnider, A Schilling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5134998     DOI： 10.1002/cpt1971126955

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

1.  Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study Group.

Authors:  M F Avril; J Bonneterre; M Delaunay; E Grosshans; P Fumoleua; L Israel; R Bugat; M Namer; D Cupissol; P Kerbrat
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  State of melanoma: an historic overview of a field in transition.

Authors:  Vikram C Gorantla; John M Kirkwood
Journal:  Hematol Oncol Clin North Am       Date:  2014-06       Impact factor: 3.722

Review 3.  Translating Molecules into Imaging-The Development of New PET Tracers for Patients with Melanoma.

Authors:  Laetitia Vercellino; Dorine de Jong; Laurent Dercle; Benoit Hosten; Brian Braumuller; Jeeban Paul Das; Aileen Deng; Antoine Moya-Plana; Camry A'Keen; Randy Yeh; Pascal Merlet; Barouyr Baroudjian; Mary M Salvatore; Kathleen M Capaccione
Journal:  Diagnostics (Basel)       Date:  2022-04-29

4.  Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.

Authors:  H Breithaupt; A Dammann; K Aigner
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.

Authors:  C I Falkson
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

6.  Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).

Authors:  G J Hill; R Ruess; R Berris; G W Philpott; P Parkin
Journal:  Ann Surg       Date:  1974-08       Impact factor: 12.969

Review 7.  WITHDRAWN: Systemic treatments for metastatic cutaneous melanoma.

Authors:  Tom Crosby; Reg Fish; Bernadette Coles; Malcolm Mason
Journal:  Cochrane Database Syst Rev       Date:  2018-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.